CLINICAL_TRIALS
trial_result
· 2021-06-01
Clinical Trial Update: Bupivacaine Effectiveness and Safety in SABER® Trial [Phase 3]
Summary
Phase 3 trial update on Bupivacaine in SABER study reports completed status with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Durect | Conditions: Postoperative Pain, Abdominal Surgery | Phase 3 | Status: COMPLETED | Results posted: 2021-06-01